Assembly生物 ASMB 深 滬
等待開盤 01-14 09:30:00 美东时间
31.60
+0.670
+2.17%
華盛通- 最 高31.62
- 今 開30.96
- 成交量 6.72万股
- 最 低 30.36
- 昨 收 30.93
- 總市值 4.92亿
- 52周最高 39.705
- 市盈率 靜 --
- 換手率 0.43%
- 52周最低 7.75
- 委 比 14.94%
- 總股本 1556.00万
- 歷史最高 811.80
- 量 比 0.53
- 振 幅 4.07%
- 歷史最低 7.692
- 每 手 1
- 風險率 8.63%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅498.16%！SurgePays Inc获Ascendiant Capital升目标价至9.75美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持SurgePays Inc"买入"评级，目标价从9.5美元升至9.75美元；Ascendiant Capital：维持Outlook Therapeutics"买入"评级，目标价从8美元升至10美元
2025-12-23 12:32
Gilead Sciences Bets On Weekly Pill To Tackle Genital Herpes
Gilead licensed Assembly Bio's long-acting HSV drugs after Phase 1b data showed antiviral activity and weekly oral dosing potential.
2025-12-23 02:46
Gilead exercises license for Assembly Biosciences herpes programs
Gilead Sciences (GILD) has exercised an option to license Assembly Biosciences (ASMB) herpes simplex virus helicase-primase inhibitor programs for recurrent genital herpes. The deal covers phase 1 ora...
2025-12-23 00:42
HC Wainwright & Co. Reiterates Buy on Assembly Biosciences, Maintains $50 Price Target
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Assembly Biosciences (NASDAQ:ASMB) with a Buy and maintains $50 price target.
2025-12-23 00:05
ASSEMBLY APPOINTS BRIDGET HOPKINS AS NEW EUROPE CEO
Proven client and operations leader to steer the next phase of growth LONDON, Dec. 18, 2025 /PRNewswire/ -- Assembly, the leading global omnichannel media agency within the Stagwell (NASDAQ:...
2025-12-18 22:49
美股大行评级 | 最高352美元！14家机构连夜上调英伟达目标价；劳氏、塔吉特、Wix.com等遭多家机构下调目标价
今日重点评级关注：Ascendiant Capital：维持Aclarion"买入"评级，目标价从22美元升至23美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从24美元升至26美元
2025-11-21 15:50
Mizuho Maintains Outperform on Assembly Biosciences, Raises Price Target to $40
Mizuho analyst Salim Syed maintains Assembly Biosciences (NASDAQ:ASMB) with a Outperform and raises the price target from $29 to $40.
2025-11-21 00:31
Assembly Biosciences Q3 EPS $(0.72) Beats $(0.78) Estimate, Sales $10.789M Beat $7.459M Estimate
Assembly Biosciences (NASDAQ:ASMB) reported quarterly losses of $(0.72) per share which beat the analyst consensus estimate of $(0.78) by 7.1 percent. This is a 52.32 percent increase over losses of $(1.51) per share
2025-11-11 05:41
美股大行评级 | 麦格理首予哔哩哔哩"跑赢大市"评级，目标价36.03美元； 高盛首予联合健康集团"买入"评级，目标价406美元
今日重点评级关注：摩根士丹利：上调Alvotech评级至"超配"，目标价14美元；蒙特利尔银行：维持PG&E"跑赢大市"评级，目标价从23美元升至25美元
2025-10-15 18:20
Assembly Biosciences Announces Upcoming Investor Conference Participation
Assembly Biosciences will participate in fireside chats at two upcoming investor conferences. Anuj Gaggar, MD, PhD, CMO, will speak at the H.C. Wainwright Liver Disease Virtual Conference on Oct 21, 2025. Jason Okazaki, CEO, and Dr. Gaggar will present at the Guggenheim 2nd Annual Healthcare Innovation Conference on Nov 12, 2025. Webcast registration and replays are available on Assembly Bio's website.
2025-10-14 11:00
